ALPAX
Price
$10.37
Change
-$0.13 (-1.24%)
Updated
Jun 13 closing price
Net Assets
2.95B
VIVAX
Price
$67.64
Change
-$0.55 (-0.81%)
Updated
Jun 13 closing price
Net Assets
188.77B
Interact to see
Advertisement

ALPAX vs VIVAX

Header iconALPAX vs VIVAX Comparison
Open Charts ALPAX vs VIVAXBanner chart's image
American Century Focused Lg Cap Val A
Price$10.37
Change-$0.13 (-1.24%)
VolumeN/A
Net Assets2.95B
Vanguard Value Index I
Price$67.64
Change-$0.55 (-0.81%)
VolumeN/A
Net Assets188.77B
ALPAX vs VIVAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ALPAX vs. VIVAX commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPAX is a Buy and VIVAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVAX has more cash in the bank: 189B vs. ALPAX (2.95B). VIVAX pays higher dividends than ALPAX: VIVAX (2.16) vs ALPAX (1.58). ALPAX was incepted earlier than VIVAX: ALPAX (25 years) vs VIVAX (33 years). ALPAX (1.09) is less costly to investors than VIVAX (0.17). ALPAX is a more actively managed with annual turnover of: 45.00 vs. VIVAX (9.00). ALPAX has a lower initial minimum investment than VIVAX: ALPAX (2500) vs VIVAX (3000). VIVAX annual gain was more profitable for investors over the last year : 8.88 vs. ALPAX (4.13). VIVAX return over 5 years is better than : 73.96 vs. ALPAX (22.08).
ALPAXVIVAXALPAX / VIVAX
Total Expense Ratio1.090.17641%
Annual Report Gross Expense Ratio1.090.17641%
Fund Existence25 years33 years-
Gain YTD4.8123.252148%
Front Load6%N/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets2.95B189B2%
Annual Yield % from dividends1.582.1673%
Returns for 1 year4.138.8846%
Returns for 3 years16.9133.2751%
Returns for 5 years22.0873.9630%
Returns for 10 years31.23105.2030%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ECX1.58-0.01
-0.63%
ECARX Holdings
UTHR283.35-2.79
-0.98%
United Therapeutics Corp
MNSB18.25-0.21
-1.14%
MainStreet Bancshares
MPW4.41-0.08
-1.78%
Medical Properties Trust
INDP0.32-0.01
-4.22%
Indaptus Therapeutics